🇺🇸 FDA
Patent

US 11013726

Substituted pyridinone-containing trycyclic compounds, and methods using same

granted A61KA61K31/4375A61K31/444

Quick answer

US patent 11013726 (Substituted pyridinone-containing trycyclic compounds, and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4375, A61K31/444, A61K31/495, A61K31/506